Page last updated: 2024-12-08

4-hydroxypipecolic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-hydroxypipecolic acid: an N-methyl-D-aspartate receptors agonist; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151907
SCHEMBL ID1512969
MeSH IDM0250022

Synonyms (29)

Synonym
4-hydroxypipecolic acid
1622-20-4
14228-16-1
4-hydroxypiperidine-2-carboxylic acid
trans-4-hydroxy-(s)-pipecolic acid-4-sulfate
2-piperidinecarboxylic acid, 4-hydroxy-
ti2y2v33cq ,
4-hydroxy-2-piperidinecarboxylic acid
unii-ti2y2v33cq
t-hpis
AKOS006310561
AB55088
SCHEMBL1512969
p-hydroxypipecolic acid
4-hydroxy-dl-pipecolic acid
ZB0512
FT-0771737
DTXSID60931402
4-hydroxypiperidine-2-carboxylicacid
F53697
Q27289977
SB45148
SB41626
SB41643
SB47782
SB47775
CS-0446374
BAA62220
EN300-197513
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]